Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
INTRODUCTION: Several clinical practice guidelines for the treatment of COVID-19 have been developed over the last two years of the pandemic; however, their methodological quality remains unclear. JUSTIFICATION: During the pandemic, multiple guidelines emerged, but clarity regarding their methodological quality was limited. OBJECTIVE: To systematically assess the quality of clinical practice guidelines for the treatment of COVID-19 published from 2021 to September 2022, using the AGREE II tool. METHODS: A systematic search of clinical practice guidelines for the treatment of mild or moderate COVID-19 was conducted using medical databases and websites of health organizations. The selected guidelines were evaluated using the AGREE II instrument. RESULTS: Eleven clinical practice guidelines (CPGs) were evaluated, showing high scores in the domains of scope and purpose (98.74%), stakeholder involvement (97.22%), rigor of development (92%), clarity of presentation (100%), applicability (85.61%), and editorial independence (100%). Although the overall quality of the guidelines was high, there was identified a need for improvement in the areas of rigor of development and applicability of the recommendations. CONCLUSIONS: We found that the quality of the evaluated clinical practice guidelines is predominantly high, and therefore, they are recommendable. However, we recognize the need to improve the descriptions of the domains of rigor of development and applicability of the recommendations.
Díaz-Castrillón FJ, Toro-Montoya AI. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia.
Rev Med Lab [Internet]. 2020 [citado 3 de octubre de 2022];24(3):183-205. Disponible en:
https://docs.bvsalud.org/biblioref/2020/05/1096519/covid-19.pdf
World Health Organization. Coronavirus [Internet]. WHO. 20d. C. [citado 3 de octubre de 2022]. Available from: https://www.who.int/es/health-topics/coronavirus#tab=tab_1
Organización Mundial de la Salud. Cronología de la respuesta de la OMS a la COVID-19 [Internet]. OMS. 2021
[citado 3 de octubre de 2022]. Disponible en:
https://www.who.int/es/news/item/29-06-2020-covidtimeline
Organización Panamericana de la Salud. COVID-19: cronología de la actuación de la OMS [Internet]. OMS. 2020 [citado 3 de octubre de 2022]. Disponible en:
https://www.who.int/es/news/item/27-04-2020-who-timeline---covid-19
Machado J. ¿La paciente cero fue realmente el primer caso de coronavirus en el país? [Internet]. Primicias. 2020 [citado 3 de octubre de 2022]. Disponible en: https://www.primicias.ec/noticias/sociedad/paciente-cero-coronavirus-ecuador/
Ministerio de Salud Pública del Ecuador. Informe epidemiológico de COVID-19, IRAG, Ecuador 2022. Situación
Epidemiológica Nacional COVID-19. Quito; 2022 ene. Disponible en:
https://www.salud.gob.ec/wp-content/uploads/2023/01/MSP_ecu_cvd19_datos_epi_-19-12-
Ortiz-Núñez R. Análisis métrico de la producción científica sobre COVID-19 en SCOPUS. Rev Cuba Inf en
Ciencias la Salud [Internet]. 2020 [citado 3 de octubre de 2022];31(3):1-20. Disponible en: https://www.redalyc.org/articulo.oa?id=377665638002
Villafuerte P. Infodemia: exceso de publicaciones de investigación supone un riesgo para la credibilidad científica [Internet]. 2020 sep [citado 3 de octubre de 2022]. Disponible en:
https://observatorio.tec.mx/edu-news/infomedia-preprints-investigacion-cientifica-pandemia
Guerrero Useda ME. El desplazamiento de prioridades de investigación hacia problemas pandémicos. Rev Educ en Ing. 21 de marzo de 2021;16(31):1-2. Disponible en:
https://educacioneningenieria.org/index.php/edi/article/view/1167
Torres-Salinas D. Ritmo de crecimiento diario de la producción científica sobre Covid-19. Análisis en bases
de datos y repositorios en acceso abierto. El Prof la Inf.2020;29(2):e290215. Disponible en: https://revista.profesionaldelainformacion.com/index.php/EPI/article/view/epi.2020.mar.15
Ferrà Canet J. Revisión sistemática de protocolos de ensayos clínicos comparativos de COVID-19 [Internet]. [Illes Balears]: Universitat de les Illes Balears; 2021 [citado 3 de octubre de 2022]. Disponible en: http://dspace.uib.es/xmlui/handle/11201/158435
Wang YY, Huang Q, Shen Q, Zi H, Li BH, Li MZ, et al. Quality of and Recommendations for Relevant Clinical
Practice Guidelines for COVID-19 Management: A Systematic Review and Critical Appraisal. Front Med [Internet].
[citado 3 de octubre de 2022];8:630765. Available from:
https://pubmed.ncbi.nlm.nih.gov/34222270/
Luo X, Liu Y, Ren M, Zhang X, Janne E, Lv M, et al. Consistency of recommendations and methodological quality of guidelines for the diagnosis and treatment of COVIDEspinoza19. J Evid Based Med [Internet]. 2021 [citado 3 de octubre de 2022];14(1):40-55.
Available from: /pmc/articles/PMC8013412/
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline
development, reporting and evaluation in health care. C Can Med Assoc J [Internet]. 2010 [citado 4 de octubre
de 2022];182(18):E839. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001530/
Hoffmann-Eßer W, Siering U, Neugebauer EAM, Brockhaus AC, Lampert U, Eikermann M. Guideline
appraisal with AGREE II: Systematic review of the current evidence on how users handle the 2 overall assessments. PLoS One [Internet]. 2017 [citado 3 de octubre de 2022];12(3):e0174831. Available from: https://pubmed.ncbi.nlm.nih.gov/28358870/
Alonso Cerezo C, Simón Martín J, García Montes MA, Fernández Jiménez G, Rodríguez Salvanés F, Rivera Franco J. Comparación de las guías de práctica clínica de riesgo vascular. Med Fam [Internet]. 2006 [citado 3 de octubre de 2022];32(6):273-85. Disponible en:
AGREE Next Steps Consortium. The AGREE II Instrument
[Electronic version] [Internet]. Dec 2017 [citado 4 de octubre de 2022]. Available from:
Epistemonikos. Epistemonikos: El más rápido y confiable buscador de evidencia en salud [Internet]. 2022 [citado 4 de octubre de 2022]. Disponible en:
https://www.epistemonikos.org/es/about_us/who_we_are
Rada G, Pérez D, Araya-Quintanilla F, Ávila C, Bravo-Soto G, Bravo-Jeria R, et al. Epistemonikos: a comprehensive database of systematic reviews for health decision-making. BMC Med Res Methodol [Internet]. 2020 [citado 4 de octubre de 2022];20(1): 286. Available from:
https://pubmed.ncbi.nlm.nih.gov/33256642/
Richards D. The TRIP database. Evid Based Dent. 2008; 9(1): 28-9. [citado 4 de octubre de 2022];9(1):28-9. Available from:
https://pubmed.ncbi.nlm.nih.gov/18364695/
Ministerio de Salud de Chile. Guía de Práctica Clínica Manejo de la infección por SARS-CoV2 [Internet]. Santiago; 2021 oct [citado 9 de octubre de 2022]. Disponible en:
https://diprece.minsal.cl/wp-content/uploads/2021/10/RE_GPC-COVID-19_04-10.pdf
Morris AM, Andany N, Bobos P, Carlin S, Ciccotelli W, Graham CM, et al. Evidence-Based Use of Therapeutics for Ambulatory Patients with COVID-19. 18 de octubre de 2021 [citado 9 de octubre de 2022];2(48). Available from:
Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, et al. ESCMID COVID-19 living guidelines:
drug treatment and clinical management. Clin Microbiol Infect [Internet]. 1 de febrero de 2022 [citado 9 de octubre de 2022];28(2):222-238. Available from:
https://pubmed.ncbi.nlm.nih.gov/34823008/
Organización Panamericana de la Salud (OPS). Directrices para la profilaxis y el manejo de pacientes con COVID-19 leve y moderada en América Latina y el Caribe [Internet]. 2021 oct [citado 9 de octubre de 2022]. Disponible en:
Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of venous thromboembolism in patients with COVID-19 Rapid guideline A national clinical guideline [Internet]. Edinburgh; 2021 dic [citado 9 de octubre de 2022]. Available from:
World Health Organization. Guideline Therapeutics and COVID-19: living guideline [Internet]. Geneva; 2022
sep [citado 9 de octubre de 2022]. Available from:
https://iris.who.int/bitstream/handle/10665/362843/WHO-2019-nCoV-therapeutics-2022.5-eng.pdf
National Health and Medical Research Council (NHMRC). Australian guidelines for the clinical care of
people with COVID-19 [Internet]. 2022 [citado 9 de octubre de 2022]. Disponible en: www.covid19evidence.net.au
Falavigna M, Belli KC, Barbosa AN, Zavascki AP, Nastri AC de SS, Santana CM, et al. Brazilian guidelines for
the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascular Surgery (SBACV), Brazilian Society of Geriatrics and Gerontology (SBGG), Brazilian Society of Infectious Diseases (SBI), Brazilian Society of Family and Community Medicine (SBFMC), and Brazilian Thoracic Society (SBPT). Brazilian J Infect Dis. 2022;26(2):102347. Available from:
https://pubmed.ncbi.nlm.nih.gov/35341739/
COVID-19 Treatment Guidelines Panel NIH. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]. National Institutes of Health. 2022 [citado 9 de octubre de 2022]. Disponible en: https://www.covid19treatmentguidelines. nih.gov/
Bhimraj A, Morgan RL, Hirsch Shumaker A, Baden L, Chi-Chung Cheng V, Edwards KM, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 [Internet]. 2022 sep [citado 4 de octubre de 2022]. Disponible en:
https://pubmed.ncbi.nlm.nih.gov/36063397/
NICE. Guideline COVID-19 rapid guideline: Managing COVID-19 [Internet]. The National Institute for
Health and Care Excellence . 2022 [citado 4 de octubre de 2022]. Disponible en:
Lanes T, Ribeiro M, Oliveira D, Junior M, Garcia F, Melo J, et al. Diretrizes de prática clínica para o tratamento
da Covid-19 no Brasil: uma revisão sistemática. Revista Cuidarte.2021;12(2):e2025. Disponible en:
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S2216-09732021000200407
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.
